1. Home
  2. GNTA vs MCHX Comparison

GNTA vs MCHX Comparison

Compare GNTA & MCHX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Genenta Science S.p.A.

GNTA

Genenta Science S.p.A.

HOLD

Current Price

$1.67

Market Cap

69.4M

Sector

Health Care

ML Signal

HOLD

Logo Marchex Inc. Class B

MCHX

Marchex Inc. Class B

N/A

Current Price

$1.81

Market Cap

67.3M

ML Signal

N/A

Company Overview

Basic Information
Metric
GNTA
MCHX
Founded
2014
2003
Country
Italy
United States
Employees
9
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
69.4M
67.3M
IPO Year
N/A
2003

Fundamental Metrics

Financial Performance
Metric
GNTA
MCHX
Price
$1.67
$1.81
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
139.7K
19.8K
Earning Date
03-24-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$90,291,000.00
Revenue This Year
N/A
$5.37
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.55
$1.32
52 Week High
$10.00
$2.14

Technical Indicators

Market Signals
Indicator
GNTA
MCHX
Relative Strength Index (RSI) 55.16 58.66
Support Level $1.30 $1.54
Resistance Level $1.70 $1.78
Average True Range (ATR) 0.12 0.09
MACD -0.01 0.01
Stochastic Oscillator 78.22 59.52

Price Performance

Historical Comparison
GNTA
MCHX

About GNTA Genenta Science S.p.A.

Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon, a product to treat glioblastoma multiforme, a solid tumor affecting the brain.

About MCHX Marchex Inc. Class B

Marchex Inc provides AI-based conversational intelligence and analytics solutions that generate insights from customer communications data. The company's products support sales, marketing, and executive teams in analyzing customer interactions across communication channels and informing business decisions. It serves companies operating in business-to-business-to-consumer (B2B2C) markets across multiple industries like automotive, home services, healthcare, real estate, and advertising. The company operates in a single segment: conversational analytics and related solutions. The company generates the majority of revenue from its conversational intelligence product offerings. Geographically, it generates the maximum revenue from the United States.

Share on Social Networks: